Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ronald Alvarez
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Living Beings
Chemicals & Drugs
Anatomy
Devices
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
75
Curiel, David
45
Siegal, Gene
36
Wang, Minghui
35
Barnes, Mack
28
Partridge, Edward
23
Hemminki, Akseli
22
Kilgore, Larry
21
Straughn, Michael
18
Huh, Warner
17
Leath, Charles
14
Mahasreshti, Parameshwar
12
Gomez-Navarro, Jesus
11
Zhu, Zeng
11
Rocconi, Rodney
11
Liu, Bin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ronald Alvarez (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Alvarez Ronald D; Mannel Robert; García Agustin A; Gallion Holly H; Lucci Joseph; Kilgore Larry C; Numnum Thomas M; Zou Sharon Xiaohan; Orlando Mauro; Tai Datchen F
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I study.
Gynecologic oncology 2009;115(3):389-95.
-
2009: Kimball Kristopher J; Rivera Angel A; Zinn Kurt R; Icyuz Mert; Saini Vaibhav; Li Jing; Zhu Zeng B; Siegal Gene P; Douglas Joanne T; Curiel David T; Alvarez Ronald D; Borovjagin Anton V
Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.
Molecular imaging : official journal of the Society for Molecular Imaging 2009;8(5):264-77.
-
2009: Matthews Kellie S; Alvarez Ronald D; Curiel David T
Advancements in adenoviral based virotherapy for ovarian cancer.
Advanced drug delivery reviews 2009;61(10):836-41.
-
2009: Frederick Peter J; Kendrick James E; Straughn J Michael; Della Manna Debbie L; Oliver Patsy G; Lin Hui-Yi; Grizzle William E; Stockard Cecil R; Alvarez Ronald D; Zhou Tong; LoBuglio Albert F; Buchsbaum Donald J
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):814-9.
-
2009: Piyathilake Chandrika J; Macaluso Maurizio; Alvarez Ronald D; Bell Walter C; Heimburger Douglas C; Partridge Edward E
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.
Cancer prevention research (Philadelphia, Pa.) 2009;2(7):658-64.
-
2009: Matthews Kellie; Noker Patricia E; Tian Baohong; Grimes Sheila D; Fulton Ronna; Schweikart Karen; Harris Raymond; Aurigemma Rose; Wang Minghui; Barnes Mack N; Siegal Gene P; Hemminki Akseli; Zinn Kurt; Curiel David T; Alvarez Ronald D
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4131-7.
-
2009: Frederick Peter J; Straughn J Michael; Alvarez Ronald D; Buchsbaum Donald J
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
Gynecologic oncology 2009;113(3):384-90.
-
2009: Berry Emily; Matthews Kellie S; Singh Diljeet K; Buttin Barbara M; Lurain John R; Alvarez Ronald D; Schink Julian
An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Gynecologic oncology 2009;113(1):63-7.
-
2008: Kimball Kristopher J; Numnum T Michael; Kirby Tyler O; Zamboni William C; Estes Jacob M; Barnes Mack N; Matei Daniela E; Koch Kevin M; Alvarez Ronald D
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma.
Gynecologic oncology 2008;111(1):95-101.
-
2008: Tsuruta Yuko; Pereboeva Larisa; Breidenbach Martina; Rein Daniel T; Wang Minghui; Alvarez Ronald D; Siegal Gene P; Dent Paul; Fisher Paul B; Curiel David T
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3582-8.
-
2008: Zhu Zeng B; Lu Baogen; Park Miey; Makhija Sharmila K; Numnum Thomas M; Kendrick James E; Wang Minghui; Tsuruta Yuko; Fisher Paul; Alvarez Ronald D; Zhou Fen; Siegal Gene P; Wu Hongju; Curiel David T
Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.
International journal of oncology 2008;32(6):1179-88.
-
2008: Matthews Kellie S; Estes Jacob M; Conner Michael G; Manne Upender; Whitworth Jenny M; Huh Warner K; Alvarez Ronald D; Straughn J Michael; Barnes Mack N; Rocconi Rodney P
Lynch syndrome in women less than 50 years of age with endometrial cancer.
Obstetrics and gynecology 2008;111(5):1161-6.
-
2008: Wright J D; Secord A A; Numnum T M; Rocconi R P; Powell M A; Berchuck A; Alvarez R D; Gibb R K; Trinkaus K; Rader J S; Mutch D G
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):400-6.
-
2008: Rocconi Rodney P; Kirby Tyler O; Seitz Robert S; Beck Rod; Straughn J Michael; Alvarez Ronald D; Huh Warner K
Lipoxygenase pathway receptor expression in ovarian cancer.
Reproductive sciences (Thousand Oaks, Calif.) 2008;15(3):321-6.
-
2008: Kendrick James E; Straughn J Michael; Oliver Patsy G; Wang Wenquan; Nan Li; Grizzle William E; Stockard Cecil R; Alvarez Ronald D; Buchsbaum Donald J
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
Gynecologic oncology 2008;108(3):591-7.
-
2008: Numnum T Michael; Makhija Sharmila; Lu Baogen; Wang Minghui; Rivera Angel; Stoff-Khalili Mariam; Alvarez Ronald D; Zhu Zeng Bian; Curiel David T
Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines.
Gynecologic oncology 2008;108(1):34-41.
-
2007: Meredith Ruby F; Buchsbaum Donald J; Alvarez Ronald D; LoBuglio Albert F
Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5643s-5645s.
-
2007: Kendrick James E; Estes Jacob M; Straughn J Michael; Alvarez Ronald D; Buchsbaum Donald J
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers.
Gynecologic oncology 2007;106(3):614-21.
-
2007: Alvarez Ronald D; Wright Thomas C;
Increased detection of high-grade cervical intraepithelial neoplasia utilizing an optical detection system as an adjunct to colposcopy.
Gynecologic oncology 2007;106(1):23-8.
-
2007: Tsuruta Yuko; Pereboeva Larisa; Glasgow Joel N; Rein Daniel T; Kawakami Yosuke; Alvarez Ronald D; Rocconi Rodney P; Siegal Gene P; Dent Paul; Fisher Paul B; Curiel David T
A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(9):2777-83.
-
2007: Huh Warner K; Kendrick James E; Alvarez Ronald D
New advances in vaccine technology and improved cervical cancer prevention.
Obstetrics and gynecology 2007;109(5):1187-92.
-
2007: Estes Jacob M; Oliver Patsy G; Straughn J Michael; Zhou Tong; Wang Wenquan; Grizzle William E; Alvarez Ronald D; Stockard Cecil R; LoBuglio Albert F; Buchsbaum Donald J
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model.
Gynecologic oncology 2007;105(2):291-8.
-
2007: Rocconi Rodney P; Zhu Zeng B; Stoff-Khalili Mariam; Rivera Angel A; Lu Baogen; Wang Minghui; Alvarez Ronald D; Curiel David T; Makhija Sharmila K
Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd).
Gynecologic oncology 2007;105(1):113-21.
-
2007: Kendrick James E; Huh Warner K; Alvarez Ronald D
LUMA cervical imaging system.
Expert review of medical devices 2007;4(2):121-9.
-
2007: Spannuth Whitney A; Leath Charles A; Huh Warner K; Barnes Mack N; Davidson Susan A; Kilgore Larry C; Partridge Edward E; Austin J Maxwell; Alvarez Ronald D
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy.
Gynecologic oncology 2007;104(3):591-5.
-
2007: Alvarez Ronald D; Wright Thomas C;
Effective cervical neoplasia detection with a novel optical detection system: a randomized trial.
Gynecologic oncology 2007;104(2):281-9.
-
2006: Rocconi Rodney P; Numnum Michael T; Zhu Zeng B; Lu Baogen; Wang Minghui; Rivera Angel A; Stoff-Khalili Mariam; Alvarez Ronald D; Curiel David T; Makhija Sharmila
Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy.
Gynecologic oncology 2006;103(3):985-9.
-
2006: Kimball Kristopher J; Numnum T Michael; Rocconi Rodney P; Alvarez Ronald D
Gene therapy for ovarian cancer.
Current oncology reports 2006;8(6):441-7.
-
2006: Belousova Natalya; Harris Raymond; Zinn Kurt; Rhodes-Selser Mary Ann; Kotov Alexander; Kotova Olga; Wang Minghui; Aurigemma Rosemarie; Zhu Zeng B; Curiel David T; Alvarez Ronald D
Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassette.
Molecular pharmacology 2006;70(5):1488-93.
-
2006: Kimball Kristopher J; Rocconi Rodney P; Straughn J Michael; Conner Michael G; Alvarez Ronald D
Unilateral cervical cancer in a patient with cervix duplex.
Gynecologic oncology 2006;103(1):346-8.
-
2006: Spannuth Whitney A; Leath Charles A; Conner Michael G; Alvarez Ronald D
Inflammatory pseudotumor of pelvic lymph nodes.
Obstetrics and gynecology 2006;108(3 Pt 2):779-82.
-
2006: Kendrick James E; Huh Warner K; Alvarez Ronald D
Novel methods to treat and prevent human papillomavirus infection.
Expert review of anti-infective therapy 2006;4(4):593-600.
-
2006: Estes Jacob M; Leath Charles A; Williams Sybilann; Modiano Manuel R; Sawyer Michael; Cohn David; Straughn J Michael; Barnes Mack N; Alvarez Ronald D
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer.
Gynecologic oncology 2006;102(2):338-42.
-
2006: Rocconi Rodney P; Straughn J Michael; Leath Charles A; Kilgore Larry C; Huh Warner K; Barnes Mack N; Partridge Edward E; Alvarez Ronald D
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
The oncologist 2006;11(4):336-41.
-
2006: Straughn J Michael; Oliver Patsy G; Zhou Tong; Wang Wenquan; Alvarez Ronald D; Grizzle William E; Buchsbaum Donald J
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
Gynecologic oncology 2006;101(1):46-54.
-
2006: Mahasreshti Parameshwar J; Kataram Manjula; Wu Hongju; Yalavarthy Laxmi Priya; Carey Delicia; Fisher Paul B; Chada Sunil; Alvarez Ronald D; Haisma Hidde J; Dent Paul; Curiel David T
Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.
Gynecologic oncology 2006;100(3):521-32.
-
2005: Rocconi Rodney P; Numnum T Michael; Stoff-Khalili Mariam; Makhija Sharmila; Alvarez Ronald D; Curiel David T
Targeted gene therapy for ovarian cancer.
Current gene therapy 2005;5(6):643-53.
-
2005: Zhu Zeng B; Makhija Sharmila K; Lu Baogen; Wang Minghui; Rivera Angel A; Kim-Park Sangae; Ulasov Ilya V; Zhou Fen; Alvarez Ronald D; Siegal Gene P; Curiel David T
Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
International journal of oncology 2005;27(1):237-46.
-
2005: Lu B; Makhija S K; Nettelbeck D M; Rivera A A; Wang M; Komarova S; Zhou F; Yamamoto M; Haisma H J; Alvarez R D; Curiel D T; Zhu Z B
Evaluation of tumor-specific promoter activities in melanoma.
Gene therapy 2005;12(4):330-8.
-
2005: Nguyen Huan H; Broker Thomas R; Chow Louise T; Alvarez Ronald D; Vu Huong L; Andrasi Judit; Brewer Lorie R; Jin Ge; Mestecky Jiri
Immune responses to human papillomavirus in genital tract of women with cervical cancer.
Gynecologic oncology 2005;96(2):452-61.
-
2005: Wang Minghui; Hemminki Akseli; Siegal Gene P; Barnes Mack N; Dmitriev Igor; Krasnykh Victor; Liu Bin; Curiel David T; Alvarez Ronald D
Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery.
Gynecologic oncology 2005;96(2):341-8.
-
2005: Numnum T Michael; Kirby Tyler O; Leath Charles A; Huh Warner K; Alvarez Ronald D; Straughn J Michael
A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
Journal of lower genital tract disease 2005;9(1):2-6.
-
2005: Breidenbach M; Rein D T; Everts M; Glasgow J N; Wang M; Passineau M J; Alvarez R D; Korokhov N; Curiel D T
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy.
Gene therapy 2005;12(2):187-93.
-
2004: Kirby Tyler O; Rivera Angel; Rein Daniel; Wang Minghui; Ulasov Ilya; Breidenbach Martina; Kataram Manjula; Contreras Juan L; Krumdieck Carlos; Yamamoto Masato; Rots Marianne G; Haisma Hidde J; Alvarez Ronald D; Mahasreshti Parameshwar J; Curiel David T
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8697-703.
-
2004: Bhoola Snehal M; Coleman Robert L; Herzog Thomas; Morris Robert; Bryant Christopher; Estes Jacob M; Alvarez Ronald D
Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer.
Gynecologic oncology 2004;95(3):564-9.
-
2004: Lam John T; Kanerva Anna; Bauerschmitz Gerd J; Takayama Koichi; Suzuki Kaori; Yamamoto Masato; Bhoola Snehal M; Liu Bin; Wang Minghui; Barnes Mack N; Alvarez Ronald D; Siegal Gene P; Curiel David T; Hemminki Akseli
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
The journal of gene medicine 2004;6(12):1333-42.
-
2004: Kirby Tyler O; Allen M Elaine; Alvarez Ronald D; Hoesley Craig J; Huh Warner K
High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus.
Journal of lower genital tract disease 2004;8(4):298-303.
-
2004: Leath Charles A; Straughn J Michael; Estes Jacob M; Kirby Tyler O; Bhoola Snehal M; Barnes Mack N; Kilgore Larry C; Alvarez Ronald D
The impact of aborted radical hysterectomy in patients with cervical carcinoma.
Gynecologic oncology 2004;95(1):204-7.
-
2004: Rein Daniel T; Breidenbach Martina; Wu Hongju; Han Tie; Haviv Yosef S; Wang Minghui; Kirby Tyler O; Kawakami Yosuke; Dall Peter; Alvarez Ronald D; Curiel David T
Gene transfer to cervical cancer with fiber-modified adenoviruses.
International journal of cancer. Journal international du cancer 2004;111(5):698-704.
-
2004: Leath Charles A; Kataram Manjula; Bhagavatula Pradeep; Gopalkrishnan Rahul V; Dent Paul; Fisher Paul B; Pereboev Alexander; Carey Delicia; Lebedeva Irina V; Haisma Hidde J; Alvarez Ronald D; Curiel David T; Mahasreshti Parameshwar J
Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma.
Gynecologic oncology 2004;94(2):352-62.
-
2004: Zhu Zeng B; Makhija Sharmila K; Lu Baogen; Wang Minghui; Rivera Angel A; Preuss Meredith; Zhou Fen; Siegal Gene P; Alvarez Ronald D; Curiel David T
Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.
Virology 2004;325(1):116-28.
-
2004: Bhoola Snehal M; Alvarez Ronald D
Novel therapies for recurrent ovarian cancer management.
Expert review of anticancer therapy 2004;4(3):437-48.
-
2004: Huh Warner K; Cestero Ramon M; Garcia Francisco A; Gold Michael A; Guido Richard S; McIntyre-Seltman Kathleen; Harper Diane M; Burke Louis; Sum Stephen T; Flewelling Ross F; Alvarez Ronald D
Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study.
American journal of obstetrics and gynecology 2004;190(5):1249-57.
-
2004: Breidenbach Martina; Rein Daniel T; Wang Minghui; Nettelbeck Dirk M; Hemminki Akseli; Ulasov Ilya; Rivera Angel R; Everts Maaike; Alvarez Ronald D; Douglas Joanne T; Curiel David T
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.
Human gene therapy 2004;15(5):509-18.
-
2004: Preuss Meredith A; Lam John T; Wang Minghui; Leath Charles A; Kataram Manjula; Mahasreshti Parameshwar J; Alvarez Ronald D; Curiel David T
Transcriptional blocks limit adenoviral replication in primary ovarian tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3189-94.
-
2004: Wu H; Han T; Lam J T; Leath C A; Dmitriev I; Kashentseva E; Barnes M N; Alvarez R D; Curiel D T
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Gene therapy 2004;11(10):874-8.
-
2004: Zhu Z B; Makhija S K; Lu B; Wang M; Kaliberova L; Liu B; Rivera A A; Nettelbeck D M; Mahasreshti P J; Leath C A; Yamamoto M; Alvarez R D; Curiel D T
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Gene therapy 2004;11(7):645-8.
-
2004: Zhu Zeng B; Makhija Sharmila K; Lu Baogen; Wang Minghui; Kaliberova Lioudmila; Liu Bin; Rivera Angel A; Nettelbeck Dirk M; Mahasreshti Parameshwar J; Leath Charles A; Barker Shannon; Yamaoto Masato; Li Fengzhi; Alvarez Ronald D; Curiel David T
Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
Cancer gene therapy 2004;11(4):256-62.
-
2004: Leath Charles A; Douglas Joanne T; Curiel David T; Alvarez Ronald D
Single-chain antibodies: A therapeutic modality for cancer gene therapy (review).
International journal of oncology 2004;24(4):765-71.
-
2004: Kanerva A; Bauerschmitz G J; Yamamoto M; Lam J T; Alvarez R D; Siegal G P; Curiel D T; Hemminki A
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma.
Gene therapy 2004;11(6):552-9.
-
2004: Straughn J Michael; Shaw Denise R; Guerrero Antonio; Bhoola Snehal M; Racelis Alicia; Wang Zhiqing; Chiriva-Internati Maurizio; Grizzle William E; Alvarez Ronald D; Lim Seah H; Strong Theresa V
Expression of sperm protein 17 (Sp17) in ovarian cancer.
International journal of cancer. Journal international du cancer 2004;108(6):805-11.
-
2004: Leath Charles A; Straughn J Michael; Conner Michael G; Barnes Mack N; Alvarez Ronald D; Partridge Edward E; Huh Warner K
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
The Journal of reproductive medicine 2004;49(2):71-5.
-
2004: Leath Charles A; Straughn J Michael; Bhoola Snehal M; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy.
Gynecologic oncology 2004;92(1):215-9.
-
2003: Estes Jacob M; Rocconi Rodney; Straughn J Michael; Bhoola Snehal; Leath Charles A; Alvarez Ronald D; Kilgore Larry C; Huh Warner K
Complications of indwelling venous access devices in patients with gynecologic malignancies.
Gynecologic oncology 2003;91(3):591-5.
-
2003: Huh Warner K; Powell Matthew; Leath Charles A; Straughn J Michael; Cohn David E; Gold Michael A; Falkner Camille A; Carey Delicia E; Herzog Thomas; Fowler Jeffrey M; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.
Gynecologic oncology 2003;91(3):470-5.
-
2003: Kanerva Anna; Zinn Kurt R; Chaudhuri Tandra R; Lam John T; Suzuki Kaori; Uil Taco G; Hakkarainen Tanja; Bauerschmitz Gerd J; Wang Minghui; Liu Bin; Cao Zhihong; Alvarez Ronald D; Curiel David T; Hemminki Akseli
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(3):449-58.
-
2003: Kirby Tyler O; Curiel David T; Alvarez Ronald D
Gene therapy for ovarian cancer: progress and potential.
Hematology/oncology clinics of North America 2003;17(4):1021-50.
-
2003: Varia Mahesh A; Stehman Frederick B; Bundy Brian N; Benda Jo Ann; Clarke-Pearson Daniel L; Alvarez Ronald D; Long Harry J;
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2849-55.
-
2003: Mahasreshti Parameshwar J; Kataram Manjula; Wang Ming H; Stockard Cecil R; Grizzle William E; Carey Delicia; Siegal Gene P; Haisma Hidde J; Alvarez Ronald D; Curiel David T
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2701-10.
-
2003: Barker S D; Dmitriev I P; Nettelbeck D M; Liu B; Rivera A A; Alvarez R D; Curiel D T; Hemminki A
Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
Gene therapy 2003;10(14):1198-204.
-
2003: Lam John T; Bauerschmitz Gerd J; Kanerva Anna; Barker Shannon D; Straughn J Michael; Wang Minghui; Barnes Mack N; Blackwell Jerry L; Siegal Gene P; Alvarez Ronald D; Curiel David T; Hemminki Akseli
Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.
Cancer gene therapy 2003;10(5):377-87.
-
2003: Straughn J Michael; Huh Warner K; Orr James W; Kelly F Joseph; Roland Phillip Y; Gold Michael A; Powell Matthew; Mutch David G; Partridge Edward E; Kilgore Larry C; Barnes Mack N; Austin J Maxwell; Alvarez Ronald D
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy.
Gynecologic oncology 2003;89(2):295-300.
-
2003: Barker Shannon D; Coolidge Candace J; Kanerva Anna; Hakkarainen Tanja; Yamamoto Masato; Liu Bin; Rivera Angel A; Bhoola Snehal M; Barnes Mack N; Alvarez Ronald D; Curiel David T; Hemminki Akseli
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
The journal of gene medicine 2003;5(4):300-10.
-
2003: Hemminki Akseli; Kanerva Anna; Liu Bin; Wang Minghui; Alvarez Ronald D; Siegal Gene P; Curiel David T
Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression.
Cancer research 2003;63(4):847-53.
-
2003: Alvarez Ronald D; Conner Michael G; Weiss Heidi; Klug Patricia M; Niwas Santosh; Manne Upender; Bacus James; Kagan Valeriy; Sexton Katherine C; Grubbs Clinton J; Eltoum Isam-Eldin; Grizzle William E
The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(2):114-9.
-
2002: Kim Robert Y; Omura George A; Alvarez Ronald D
Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary.
Oncology (Williston Park, N.Y.) 2002;16(12):1669-78; discussion 1678-80.
-
2002: Kim Robert Y; Alvarez Ronald D; Omura George A
Advances in the treatment of gynecologic malignancies. Part 1: Cancers of the cervix and vulva.
Oncology (Williston Park, N.Y.) 2002;16(11):1510-7, 1521; discussion 1522-4, 1528, 1530.
-
2002: Alvarez Ronald D; Huh Warner K; Khazaeli M B; Meredith Ruby F; Partridge Edward E; Kilgore Larry C; Grizzle William E; Shen Sui; Austin J Max; Barnes Mack N; Carey Delicia; Schlom Jeffrey; LoBuglio Albert F
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2806-11.
-
2002: Hemminki Akseli; Wang Minghui; Desmond Renee A; Strong Theresa V; Alvarez Ronald D; Curiel David T
Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy.
Human gene therapy 2002;13(12):1505-14.
-
2002: Kanerva Anna; Wang Minghui; Bauerschmitz Gerd J; Lam John T; Desmond Renee A; Bhoola Snehal M; Barnes Mack N; Alvarez Ronald D; Siegal Gene P; Curiel David T; Hemminki Akseli
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(6):695-704.
-
2002: Hemminki Akseli; Zinn Kurt R; Liu Bin; Chaudhuri Tandra R; Desmond Renee A; Rogers Buck E; Barnes Mack N; Alvarez Ronald D; Curiel David T
In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus.
Journal of the National Cancer Institute 2002;94(10):741-9.
-
2002: Barnes Mack N; Coolidge Candace J; Hemminki Akseli; Alvarez Ronald D; Curiel David T
Conditionally replicative adenoviruses for ovarian cancer therapy.
Molecular cancer therapeutics 2002;1(6):435-9.
-
2002: Bauerschmitz Gerd J; Lam John T; Kanerva Anna; Suzuki Kaori; Nettelbeck Dirk M; Dmitriev Igor; Krasnykh Victor; Mikheeva Galina V; Barnes Mack N; Alvarez Ronald D; Dall Peter; Alemany Ramon; Curiel David T; Hemminki Akseli
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.
Cancer research 2002;62(5):1266-70.
-
2002: Arafat W O; Gómez-Navarro J; Buchsbaum D J; Xiang J; Wang M; Casado E; Barker S D; Mahasreshti P J; Haisma H J; Barnes M N; Siegal G P; Alvarez R D; Hemminki A; Nettelbeck D M; Curiel D T
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.
Gene therapy 2002;9(4):256-62.
-
2002: Straughn J Michael; Huh Warner K; Kelly F Joseph; Leath Charles A; Kleinberg Marc J; Hyde Johnny; Numnum T Michael; Zhang Yuting; Soong Seng-Jaw; Austin J Maxwell; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
Conservative management of stage I endometrial carcinoma after surgical staging.
Gynecologic oncology 2002;84(2):194-200.
-
2002: Kanerva Anna; Mikheeva Galina V; Krasnykh Victor; Coolidge Candace J; Lam John T; Mahasreshti Parameshwar J; Barker Shannon D; Straughn Michael; Barnes Mack N; Alvarez Ronald D; Hemminki Akseli; Curiel David T
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):275-80.
-
2002: Hemminki Akseli; Alvarez Ronald D
Adenoviruses in oncology: a viable option?
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2002;16(2):77-87.
-
2002: Huh Warner K; Barnes Mack N; Kelley F Joseph; Alvarez Ronald D
Gene therapy.
Cancer treatment and research 2002;107():133-57.
-
2001: Huh W K; Gomez-Navarro J; Arafat W O; Xiang J; Mahasreshti P J; Alvarez R D; Barnes M N; Curiel D T
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
Gynecologic oncology 2001;83(2):370-7.
-
2001: Hemminki A; Belousova N; Zinn K R; Liu B; Wang M; Chaudhuri T R; Rogers B E; Buchsbaum D J; Siegal G P; Barnes M N; Gomez-Navarro J; Curiel D T; Alvarez R D
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(3):223-31.
-
2001: Ponnazhagan S; Curiel D T; Shaw D R; Alvarez R D; Siegal G P
Adeno-associated virus for cancer gene therapy.
Cancer research 2001;61(17):6313-21.
-
2001: Meredith R F; Alvarez R D; Partridge E E; Khazaeli M B; Lin C Y; Macey D J; Austin J M; Kilgore L C; Grizzle W E; Schlom J; LoBuglio A F
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
Cancer biotherapy & radiopharmaceuticals 2001;16(4):305-15.
-
2001: Casado E; Nettelbeck D M; Gomez-Navarro J; Hemminki A; Gonzalez Baron M; Siegal G P; Barnes M N; Alvarez R D; Curiel D T
Transcriptional targeting for ovarian cancer gene therapy.
Gynecologic oncology 2001;82(2):229-37.
-
2001: Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge C J; Arafat W O; Barker S D; Wang M H; Mahasreshti P J; Hemminki A; Gonzalez-Baron M; Barnes M N; Pustilnik T B; Siegal G P; Alvarez R D; Curiel D T
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2496-504.
-
2001: Mahasreshti P J; Navarro J G; Kataram M; Wang M H; Carey D; Siegal G P; Barnes M N; Nettelbeck D M; Alvarez R D; Hemminki A; Curiel D T
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):2057-66.
-
2001: Barker S D; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik T B; Hemminki A; Siegal G P; Alvarez R D; Curiel D T
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
Gynecologic oncology 2001;82(1):57-63.
-
2001: Broker T R; Jin G; Croom-Rivers A; Bragg S M; Richardson M; Chow L T; Vermund S H; Alvarez R D; Pappas P G; Squires K E; Hoesley C J
Viral latency--the papillomavirus model.
Developments in biologicals 2001;106():443-51; discussion 452-3, 465-75.
-
2000: Arafat W O; Casado E; Wang M; Alvarez R D; Siegal G P; Glorioso J C; Curiel D T; Gómez-Navarro J
Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4442-8.
-
2000: Kelly F J; Miller C R; Buchsbaum D J; Gomez-Navarro J; Barnes M N; Alvarez R D; Curiel D T
Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4323-33.
-
2000: Alvarez R D; Gomez-Navarro J; Wang M; Barnes M N; Strong T V; Arani R B; Arafat W; Hughes J V; Siegal G P; Curiel D T
Adenoviral-mediated suicide gene therapy for ovarian cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(5):524-30.
-
2000: Kim R Y; Alvarez R D
Recent developments in chemoradiotherapy for locally advanced cancer of the cervix.
Oncology (Williston Park, N.Y.) 2000;14(9):1327-31, 1335; discussion 1336-8.
-
2000: Arafat W; Gómez-Navarro J; Xiang J; Siegal G P; Alvarez R D; Curiel D T
Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target.
Cancer gene therapy 2000;7(9):1250-6.
-
2000: Alvarez R D; Barnes M N; Gomez-Navarro J; Wang M; Strong T V; Arafat W; Arani R B; Johnson M R; Roberts B L; Siegal G P; Curiel D T
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3081-7.
-
2000: Blackwell J L; Li H; Gomez-Navarro J; Dmitriev I; Krasnykh V; Richter C A; Shaw D R; Alvarez R D; Curiel D T; Strong T V
Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.
Human gene therapy 2000;11(12):1657-69.
-
2000: Arafat W O; Gómez-Navarro J; Xiang J; Barnes M N; Mahasreshti P; Alvarez R D; Siegal G P; Badib A O; Buchsbaum D; Curiel D T; Stackhouse M A
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(6):545-54.
-
2000: Xiang J; Gómez-Navarro J; Arafat W; Liu B; Barker S D; Alvarez R D; Siegal G P; Curiel D T
Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.
The journal of gene medicine 2000;2(2):97-106.
-
1999: Barnes M N; Roland P Y; Straughn M; Kilgore L C; Alvarez R D; Partridge E E
A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact.
Gynecologic oncology 1999;74(3):443-7.
-
1999: Rancourt C; Piché A; Gomez-Navarro J; Wang M; Alvarez R D; Siegal G P; Fuller G M; Jones S A; Curiel D T
Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(1):43-50.
-
1998: Naumann R W; Alvarez R D; Omura G A; Segars E; Kilgore L C; Partridge E E
A phase I study of paclitaxel, doxorubicin, and cisplatin in patients with previously untreated epithelial ovarian cancer.
Gynecologic oncology 1998;71(3):450-3.
-
1998: Wang M; Rancourt C; Navarro J G; Krisky D; Marconi P; Oligino T; Alvarez R D; Siegal G P; Glorioso J C; Curiel D T
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.
Gynecologic oncology 1998;71(2):278-87.
-
1998: Kelly J; Alvarez R D; Roland P Y
Arteriovenous malformation presenting as a complex pelvic mass with ureteral obstruction. A case report.
The Journal of reproductive medicine 1998;43(10):916-8.
-
1998: Rancourt C; Rogers B E; Sosnowski B A; Wang M; Piché A; Pierce G F; Alvarez R D; Siegal G P; Douglas J T; Curiel D T
Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2455-61.
-
1998: Robertson M W; Wang M; Siegal G P; Rosenfeld M; Ashford R S; Alvarez R D; Garver R I; Curiel D T
Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells.
Cancer gene therapy 1998;5(5):331-6.
-
1998: Grim J E; Siegal G P; Alvarez R D; Curiel D T
Intracellular expression of the anti-erbB-2 sFv N29 fails to accomplish efficient target modulation.
Biochemical and biophysical research communications 1998;250(3):699-703.
-
1998: Robertson M W; Barnes M N; Rancourt C; Wang M; Grim J; Alvarez R D; Siegal G P; Curiel D T
Gene therapy for ovarian carcinoma.
Seminars in oncology 1998;25(3):397-406.
-
1998: Grim J; Deshane J; Siegal G P; Alvarez R D; DiFiore P; Curiel D T
The level of erbB2 expression predicts sensitivity to the cytotoxic effects of an intracellular anti-erbB2 sFv.
Journal of molecular medicine (Berlin, Germany) 1998;76(6):451-8.
-
1998: Wang-Johanning F; Gillespie G Y; Grim J; Rancourt C; Alvarez R D; Siegal G P; Curiel D T
Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.
Cancer research 1998;58(9):1893-900.
-
1998: Gómez-Navarro J; Siegal G P; Alvarez R D; Curiel D T
Gene therapy: ovarian carcinoma as the paradigm.
American journal of clinical pathology 1998;109(4):444-67.
-
1998: Rancourt C; Robertson M W; Wang M; Goldman C K; Kelly J F; Alvarez R D; Siegal G P; Curiel D T
Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):265-70.
-
1997: Alvarez R D; Partridge E E; Khazaeli M B; Plott G; Austin M; Kilgore L; Russell C D; Liu T; Grizzle W E; Schlom J; LoBuglio A F; Meredith R F
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.
Gynecologic oncology 1997;65(1):94-101.
-
1997: Deshane J; Siegal G P; Wang M; Wright M; Bucy R P; Alvarez R D; Curiel D T
Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.
Gynecologic oncology 1997;64(3):378-85.
-
1997: Barnes M N; Deshane J S; Rosenfeld M; Siegal G P; Curiel D T; Alvarez R D
Gene therapy and ovarian cancer: a review.
Obstetrics and gynecology 1997;89(1):145-55.
-
1996: Naumann R W; Crispens M A; Alvarez R D; Partridge E E; Shingleton H M; Kilgore L C
Treatment of cervical dysplasia with large loop excision of the transformation zone: is endocervical curettage necessary?
Southern medical journal 1996;89(10):961-5.
-
1996: Meredith R F; Partridge E E; Alvarez R D; Khazaeli M B; Plott G; Russell C D; Wheeler R H; Liu T; Grizzle W E; Schlom J; LoBuglio A F
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1491-6.
-
1996: Rosenfeld M E; Wang M; Siegal G P; Alvarez R D; Mikheeva G; Krasnykh V; Curiel D T
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma.
Journal of molecular medicine (Berlin, Germany) 1996;74(8):455-62.
-
1996: Barnes M N; Deshane J S; Siegal G P; Alvarez R D; Curiel D T
Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1089-95.
-
1996: Bell M C; Schmidt-Grimminger D C; Connor M G; Alvarez R D
A cervical teratoma with invasive squamous cell carcinoma in an HIV-infected patient: a case report.
Gynecologic oncology 1996;60(3):475-9.
-
1996: Deshane J; Grim J; Loechel S; Siegal G P; Alvarez R D; Curiel D T
Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.
Cancer gene therapy 1996;3(2):89-98.
-
1996: Morris M; Alvarez R D; Kinney W K; Wilson T O
Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Gynecologic oncology 1996;60(2):288-91.
-
1995: Rosenfeld M E; Feng M; Michael S I; Siegal G P; Alvarez R D; Curiel D T
Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1571-80.
-
1995: Deshane J; Siegal G P; Alvarez R D; Wang M H; Feng M; Cabrera G; Liu T; Kay M; Curiel D T
Targeted tumor killing via an intracellular antibody against erbB-2.
The Journal of clinical investigation 1995;96(6):2980-9.
-
1995: Siller B S; Gelder M S; Alvarez R D; Partridge E E
Massive edema of the ovary associated with androgenic manifestations.
Southern medical journal 1995;88(11):1153-5.
-
1995: Deshane J; Cabrera G; Grim J E; Siegal G P; Pike J; Alvarez R D; Curiel D T
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.
Gynecologic oncology 1995;59(1):8-14.
-
1995: Roland P Y; Naumann R W; Alvarez R D; Kilgore L C; Partridge E E
A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears.
Gynecologic oncology 1995;59(1):75-80.
-
1995: Siller B S; Alvarez R D; Conner W D; McCullough C H; Kilgore L C; Partridge E E; Austin J M
T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.
Gynecologic oncology 1995;57(3):335-9.
-
1995: Liu T; Soong S J; Alvarez R D; Butterworth C E
A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(4):373-80.
-
1995: Kilgore L C; Partridge E E; Alvarez R D; Austin J M; Shingleton H M; Noojin F; Conner W
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling.
Gynecologic oncology 1995;56(1):29-33.
-
1994: Naumann R W; Bell M C; Alvarez R D; Edwards R P; Partridge E E; Helm C W; Shingleton H M; McGee J A; Higgins R V; Hall J B
LLETZ is an acceptable alternative to diagnostic cold-knife conization.
Gynecologic oncology 1994;55(2):224-8.
-
1994: Higgins R V; Hall J B; McGee J A; Laurent S; Alvarez R D; Partridge E E
Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Obstetrics and gynecology 1994;84(2):174-8.
-
1994: Alvarez R D; Helm C W; Edwards R P; Naumann R W; Partridge E E; Shingleton H M; McGee J A; Hall J B; Higgins R V; Malone J M
Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia.
Gynecologic oncology 1994;52(2):175-9.
-
1993: Alvarez R D; Kilgore L C; Partridge E E; Austin J M; Shingleton H M
Staging ovarian cancer diagnosed during laparoscopy: accuracy rather than immediacy.
Southern medical journal 1993;86(11):1256-8.
-
1993: Gelder M S; Alvarez R D; Partridge E E
Ureteroarterial fistulae in exenteration patients with indwelling ureteral stents.
Gynecologic oncology 1993;50(3):365-70.
-
1993: Naumann R W; Alvarez R D; Partridge E E; Kilgore L C; Austin J M
The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
Gynecologic oncology 1993;50(3):291-3.
-
1993: Partridge E E; Gunter B C; Gelder M S; Alvarez R D; Soong S J; Austin J M; Kilgore L C
The validity and significance of substages of advanced ovarian cancer.
Gynecologic oncology 1993;48(2):236-41.
-
1991: Alvarez R D; Gleason B P; Gore H; Partridge E E
Coexisting intraductal breast carcinoma and metastatic choriocarcinoma presenting as a breast mass.
Gynecologic oncology 1991;43(3):295-9.
-
1991: Alvarez R D; Potter M E; Soong S J; Gay F L; Hatch K D; Partridge E E; Shingleton H M
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients.
Gynecologic oncology 1991;43(2):108-12.
-
1990: Potter M E; Alvarez R D; Shingleton H M; Soong S J; Hatch K D
Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy?
Gynecologic oncology 1990;37(1):78-81.
-
1990: Potter M E; Alvarez R D; Gay F L; Shingleton H M; Soong S J; Hatch K D
Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer.
Gynecologic oncology 1990;37(1):74-7.
-
1989: Alvarez R D; Grizzle W E; Smith L J; Miller D M
Compensatory ovarian hypertrophy occurs by a mechanism distinct from compensatory growth in the regenerating liver.
American journal of obstetrics and gynecology 1989;161(6 Pt 1):1653-7.
-
1989: Alvarez R D; Soong S J; Kinney W K; Reid G C; Schray M F; Podratz K C; Morley G W; Shingleton H M
Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix.
Gynecologic oncology 1989;35(2):130-5.
-
1989: Kinney W K; Alvarez R D; Reid G C; Schray M F; Soong S J; Morley G W; Podratz K C; Shingleton H M
Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study.
Gynecologic oncology 1989;34(3):258-62.
-
1988: Alvarez R D
Gastrointestinal complications in gynecologic surgery: a review for the general gynecologist.
Obstetrics and gynecology 1988;72(3 Pt 2):533-40.
-
1988: Alvarez R D; Kilgore L C; Huddleston J F
A comparison of mezlocillin versus clindamycin/gentamicin for the treatment of postcesarean endomyometritis.
American journal of obstetrics and gynecology 1988;158(2):425-9.
-
1987: Alvarez R D; To A; Boots L R; Shingleton H M; Hatch K D; Hubbard J; Soong S J; Potter M E
CA125 as a serum marker for poor prognosis in ovarian malignancies.
Gynecologic oncology 1987;26(3):284-9.
Sign-in to see more
